{"transactions":[{"id":4614644,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & Interim CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-10T20:23:05.000Z","date":"2026-09-08","kind":"exercise","planned":true,"acquired":false,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option vest in sixteen equal quarterly installments following April 5, 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":34252,"derivative":{"exercise_price":3.7898,"expiration_date":"2033-04-05","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001470831-26-000883","document":"wk-form4_1789071782.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000147083126000883/wk-form4_1789071782.xml","form_type":"4"}},{"id":4614643,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & Interim CEO"}}],"security":"Common Stock","published_at":"2026-09-10T20:23:05.000Z","date":"2026-09-08","kind":"sale","planned":true,"acquired":false,"shares":3442,"price":23.4349,"value":80662.9258,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.26 to $23.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":181641,"source":{"system":"sec-edgar","filing":"0001470831-26-000883","document":"wk-form4_1789071782.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000147083126000883/wk-form4_1789071782.xml","form_type":"4"}},{"id":4614642,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & Interim CEO"}}],"security":"Common Stock","published_at":"2026-09-10T20:23:05.000Z","date":"2026-09-08","kind":"sale","planned":true,"acquired":false,"shares":14058,"price":22.7666,"value":320052.8628,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.26 to $23.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":185083,"source":{"system":"sec-edgar","filing":"0001470831-26-000883","document":"wk-form4_1789071782.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000147083126000883/wk-form4_1789071782.xml","form_type":"4"}},{"id":4614641,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, COO & Interim CEO"}}],"security":"Common Stock","published_at":"2026-09-10T20:23:05.000Z","date":"2026-09-08","kind":"exercise","planned":true,"acquired":true,"shares":17500,"price":3.7898,"value":66321.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2026."}],"balance_after":199141,"source":{"system":"sec-edgar","filing":"0001470831-26-000883","document":"wk-form4_1789071782.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000147083126000883/wk-form4_1789071782.xml","form_type":"4"}},{"id":689506,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-12T20:19:10.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in sixteen equal quarterly installments following April 5, 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":51752,"derivative":{"exercise_price":3.7898,"expiration_date":"2033-04-05","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001470831-26-000812","document":"wk-form4_1786565947.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000147083126000812/wk-form4_1786565947.xml","form_type":"4"}},{"id":689505,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-08-12T20:19:10.000Z","date":"2026-08-10","kind":"sale","planned":true,"acquired":false,"shares":18750,"price":27.9751,"value":524533.125,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.56 to $28.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":181641,"source":{"system":"sec-edgar","filing":"0001470831-26-000812","document":"wk-form4_1786565947.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000147083126000812/wk-form4_1786565947.xml","form_type":"4"}},{"id":689504,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-08-12T20:19:10.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":true,"shares":18750,"price":3.7898,"value":71058.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2026."}],"balance_after":200391,"source":{"system":"sec-edgar","filing":"0001470831-26-000812","document":"wk-form4_1786565947.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000147083126000812/wk-form4_1786565947.xml","form_type":"4"}},{"id":711314,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-10T20:10:50.000Z","date":"2026-07-08","kind":"exercise","planned":true,"acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this option vest in sixteen equal quarterly installments following April 5, 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":70502,"derivative":{"exercise_price":3.7898,"expiration_date":"2033-04-05","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001470831-26-000701","document":"wk-form4_1783714248.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000147083126000701/wk-form4_1783714248.xml","form_type":"4"}},{"id":711313,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-07-10T20:10:50.000Z","date":"2026-07-09","kind":"sale","planned":true,"acquired":false,"shares":536,"price":29,"value":15544.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2026."}],"balance_after":181641,"source":{"system":"sec-edgar","filing":"0001470831-26-000701","document":"wk-form4_1783714248.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000147083126000701/wk-form4_1783714248.xml","form_type":"4"}},{"id":711312,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-07-10T20:10:50.000Z","date":"2026-07-08","kind":"sale","planned":true,"acquired":false,"shares":1075,"price":30.3549,"value":32631.5175,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.25 to $30.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":182177,"source":{"system":"sec-edgar","filing":"0001470831-26-000701","document":"wk-form4_1783714248.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000147083126000701/wk-form4_1783714248.xml","form_type":"4"}},{"id":711311,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-07-10T20:10:50.000Z","date":"2026-07-08","kind":"sale","planned":true,"acquired":false,"shares":4306,"price":29.7961,"value":128302.0066,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.23 to $30.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":183252,"source":{"system":"sec-edgar","filing":"0001470831-26-000701","document":"wk-form4_1783714248.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000147083126000701/wk-form4_1783714248.xml","form_type":"4"}},{"id":711310,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-07-10T20:10:50.000Z","date":"2026-07-08","kind":"sale","planned":true,"acquired":false,"shares":22833,"price":28.7589,"value":656651.9637,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.21 to $29.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":187558,"source":{"system":"sec-edgar","filing":"0001470831-26-000701","document":"wk-form4_1783714248.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000147083126000701/wk-form4_1783714248.xml","form_type":"4"}},{"id":711309,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-07-10T20:10:50.000Z","date":"2026-07-08","kind":"exercise","planned":true,"acquired":true,"shares":18750,"price":3.7898,"value":71058.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2026."}],"balance_after":210391,"source":{"system":"sec-edgar","filing":"0001470831-26-000701","document":"wk-form4_1783714248.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000147083126000701/wk-form4_1783714248.xml","form_type":"4"}},{"id":775430,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-18T20:24:16.000Z","date":"2026-05-15","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":101334,"derivative":{"exercise_price":3.7898,"expiration_date":"2033-08-08","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001628280-26-035937","document":"wk-form4_1779135854.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828026035937/wk-form4_1779135854.xml","form_type":"4"}},{"id":775429,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-05-18T20:24:16.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":4500,"price":20.2919,"value":91313.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.08 to $20.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":191641,"source":{"system":"sec-edgar","filing":"0001628280-26-035937","document":"wk-form4_1779135854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828026035937/wk-form4_1779135854.xml","form_type":"4"}},{"id":775428,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-05-18T20:24:16.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":20.2919,"value":162335.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.08 to $20.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":196141,"source":{"system":"sec-edgar","filing":"0001628280-26-035937","document":"wk-form4_1779135854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828026035937/wk-form4_1779135854.xml","form_type":"4"}},{"id":775427,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-05-18T20:24:16.000Z","date":"2026-05-15","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":3.7898,"value":30318.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."}],"balance_after":204141,"source":{"system":"sec-edgar","filing":"0001628280-26-035937","document":"wk-form4_1779135854.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828026035937/wk-form4_1779135854.xml","form_type":"4"}},{"id":805909,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-17T20:55:17.000Z","date":"2026-04-15","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":109334,"derivative":{"exercise_price":3.7898,"expiration_date":"2033-08-08","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001628280-26-025817","document":"wk-form4_1776459315.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828026025817/wk-form4_1776459315.xml","form_type":"4"}},{"id":805908,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-04-17T20:55:17.000Z","date":"2026-04-15","kind":"sale","planned":true,"acquired":false,"shares":4500,"price":23.0073,"value":103532.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.58 to $23.255, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":196141,"source":{"system":"sec-edgar","filing":"0001628280-26-025817","document":"wk-form4_1776459315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828026025817/wk-form4_1776459315.xml","form_type":"4"}},{"id":805907,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-04-17T20:55:17.000Z","date":"2026-04-15","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":23.0073,"value":184058.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.58 to $23.255, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":200641,"source":{"system":"sec-edgar","filing":"0001628280-26-025817","document":"wk-form4_1776459315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828026025817/wk-form4_1776459315.xml","form_type":"4"}},{"id":805906,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-04-17T20:55:17.000Z","date":"2026-04-15","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":3.7898,"value":30318.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."}],"balance_after":208641,"source":{"system":"sec-edgar","filing":"0001628280-26-025817","document":"wk-form4_1776459315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828026025817/wk-form4_1776459315.xml","form_type":"4"}},{"id":838663,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-17T21:36:59.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":117334,"derivative":{"exercise_price":3.7898,"expiration_date":"2033-08-08","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001628280-26-018934","document":"wk-form4_1773783415.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828026018934/wk-form4_1773783415.xml","form_type":"4"}},{"id":838662,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-03-17T21:36:59.000Z","date":"2026-03-16","kind":"sale","planned":true,"acquired":false,"shares":4500,"price":19.6571,"value":88456.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.34 to $19.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":200641,"source":{"system":"sec-edgar","filing":"0001628280-26-018934","document":"wk-form4_1773783415.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828026018934/wk-form4_1773783415.xml","form_type":"4"}},{"id":838661,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-03-17T21:36:59.000Z","date":"2026-03-16","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":19.6571,"value":157256.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.34 to $19.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":205141,"source":{"system":"sec-edgar","filing":"0001628280-26-018934","document":"wk-form4_1773783415.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828026018934/wk-form4_1773783415.xml","form_type":"4"}},{"id":838660,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-03-17T21:36:59.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":3.7898,"value":30318.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."}],"balance_after":213141,"source":{"system":"sec-edgar","filing":"0001628280-26-018934","document":"wk-form4_1773783415.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828026018934/wk-form4_1773783415.xml","form_type":"4"}},{"id":859009,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-06T00:10:29.000Z","date":"2026-03-03","kind":"exercise","planned":true,"acquired":false,"shares":12892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":125334,"derivative":{"exercise_price":3.7898,"expiration_date":"2033-08-08","underlying":"Common Stock","underlying_shares":12892},"source":{"system":"sec-edgar","filing":"0001628280-26-015423","document":"wk-form4_1772755827.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828026015423/wk-form4_1772755827.xml","form_type":"4"}},{"id":859008,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-03-06T00:10:29.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":4500,"price":18.1631,"value":81733.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":205141,"source":{"system":"sec-edgar","filing":"0001628280-26-015423","document":"wk-form4_1772755827.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828026015423/wk-form4_1772755827.xml","form_type":"4"}},{"id":859007,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-03-06T00:10:29.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":12892,"price":18.1631,"value":234158.6852,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":209641,"source":{"system":"sec-edgar","filing":"0001628280-26-015423","document":"wk-form4_1772755827.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828026015423/wk-form4_1772755827.xml","form_type":"4"}},{"id":859006,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-03-06T00:10:29.000Z","date":"2026-03-03","kind":"exercise","planned":true,"acquired":true,"shares":12892,"price":3.7898,"value":48858.1016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."}],"balance_after":222533,"source":{"system":"sec-edgar","filing":"0001628280-26-015423","document":"wk-form4_1772755827.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828026015423/wk-form4_1772755827.xml","form_type":"4"}},{"id":877686,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-27T21:13:56.000Z","date":"2026-02-25","kind":"exercise","planned":true,"acquired":false,"shares":3108,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":138226,"derivative":{"exercise_price":3.7898,"expiration_date":"2033-08-08","underlying":"Common Stock","underlying_shares":3108},"source":{"system":"sec-edgar","filing":"0001628280-26-012823","document":"wk-form4_1772226833.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828026012823/wk-form4_1772226833.xml","form_type":"4"}},{"id":877685,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-02-27T21:13:56.000Z","date":"2026-02-25","kind":"sale","planned":true,"acquired":false,"shares":523,"price":18.0395,"value":9434.6585,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":209641,"source":{"system":"sec-edgar","filing":"0001628280-26-012823","document":"wk-form4_1772226833.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828026012823/wk-form4_1772226833.xml","form_type":"4"}},{"id":877684,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-02-27T21:13:56.000Z","date":"2026-02-25","kind":"sale","planned":true,"acquired":false,"shares":3108,"price":18.0395,"value":56066.766,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":210164,"source":{"system":"sec-edgar","filing":"0001628280-26-012823","document":"wk-form4_1772226833.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828026012823/wk-form4_1772226833.xml","form_type":"4"}},{"id":877683,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-02-27T21:13:56.000Z","date":"2026-02-25","kind":"exercise","planned":true,"acquired":true,"shares":3108,"price":3.7898,"value":11778.6984,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."}],"balance_after":213272,"source":{"system":"sec-edgar","filing":"0001628280-26-012823","document":"wk-form4_1772226833.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828026012823/wk-form4_1772226833.xml","form_type":"4"}},{"id":919724,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T21:38:05.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in sixteen equal quarterly installments following February 2, 2026, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":16.76,"expiration_date":"2036-02-02","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001628280-26-005487","document":"wk-form4_1770241082.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828026005487/wk-form4_1770241082.xml","form_type":"4"}},{"id":931296,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-01-26T21:34:51.000Z","date":"2026-01-22","kind":"sale","planned":true,"acquired":false,"shares":3828,"price":18.1024,"value":69295.9872,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":210164,"source":{"system":"sec-edgar","filing":"0001628280-26-003419","document":"wk-form4_1769463288.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828026003419/wk-form4_1769463288.xml","form_type":"4"}},{"id":935587,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-01-20T21:52:40.000Z","date":"2026-01-15","kind":"sale","planned":true,"acquired":false,"shares":149,"price":18.02,"value":2684.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."}],"balance_after":213992,"source":{"system":"sec-edgar","filing":"0001628280-26-002656","document":"wk-form4_1768945958.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828026002656/wk-form4_1768945958.xml","form_type":"4"}},{"id":958456,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-29T22:18:10.000Z","date":"2025-12-26","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest in sixteen equal quarterly installments following October 4, 2022, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":39909,"derivative":{"exercise_price":4.4369,"expiration_date":"2032-10-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001628280-25-059045","document":"wk-form4_1767046687.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828025059045/wk-form4_1767046687.xml","form_type":"4"}},{"id":958455,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-12-29T22:18:10.000Z","date":"2025-12-26","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":4.4369,"value":110922.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an ISO exercise and hold to acquire and retain direct share ownership of the issuer."}],"balance_after":214141,"source":{"system":"sec-edgar","filing":"0001628280-25-059045","document":"wk-form4_1767046687.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000162828025059045/wk-form4_1767046687.xml","form_type":"4"}},{"id":967949,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-16T21:52:02.000Z","date":"2025-12-15","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":141334,"derivative":{"exercise_price":3.7898,"expiration_date":"2033-08-08","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0002034665-25-000011","document":"wk-form4_1765921919.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000203466525000011/wk-form4_1765921919.xml","form_type":"4"}},{"id":967948,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-12-16T21:52:02.000Z","date":"2025-12-15","kind":"sale","planned":true,"acquired":false,"shares":4500,"price":18.6838,"value":84077.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.55 to $18.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":189141,"source":{"system":"sec-edgar","filing":"0002034665-25-000011","document":"wk-form4_1765921919.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000203466525000011/wk-form4_1765921919.xml","form_type":"4"}},{"id":967947,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-12-16T21:52:02.000Z","date":"2025-12-15","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":18.6838,"value":149470.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.55 to $18.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":193641,"source":{"system":"sec-edgar","filing":"0002034665-25-000011","document":"wk-form4_1765921919.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000203466525000011/wk-form4_1765921919.xml","form_type":"4"}},{"id":967946,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-12-16T21:52:02.000Z","date":"2025-12-15","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":3.7898,"value":30318.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."}],"balance_after":201641,"source":{"system":"sec-edgar","filing":"0002034665-25-000011","document":"wk-form4_1765921919.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000203466525000011/wk-form4_1765921919.xml","form_type":"4"}},{"id":988943,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-25T23:41:34.000Z","date":"2025-11-21","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":149334,"derivative":{"exercise_price":3.7898,"expiration_date":"2033-08-08","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0002034665-25-000009","document":"wk-form4_1764114091.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000203466525000009/wk-form4_1764114091.xml","form_type":"4"}},{"id":988942,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-11-25T23:41:34.000Z","date":"2025-11-21","kind":"sale","planned":true,"acquired":false,"shares":4500,"price":18.047,"value":81211.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":193641,"source":{"system":"sec-edgar","filing":"0002034665-25-000009","document":"wk-form4_1764114091.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000203466525000009/wk-form4_1764114091.xml","form_type":"4"}},{"id":988941,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-11-25T23:41:34.000Z","date":"2025-11-21","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":18.047,"value":144376.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":198141,"source":{"system":"sec-edgar","filing":"0002034665-25-000009","document":"wk-form4_1764114091.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000203466525000009/wk-form4_1764114091.xml","form_type":"4"}},{"id":988940,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-11-25T23:41:34.000Z","date":"2025-11-21","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":3.7898,"value":30318.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."}],"balance_after":206141,"source":{"system":"sec-edgar","filing":"0002034665-25-000009","document":"wk-form4_1764114091.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000203466525000009/wk-form4_1764114091.xml","form_type":"4"}},{"id":1017736,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-16T20:41:41.000Z","date":"2025-10-15","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":157334,"derivative":{"exercise_price":3.7898,"expiration_date":"2033-08-08","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0002034665-25-000006","document":"wk-form4_1760647298.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000203466525000006/wk-form4_1760647298.xml","form_type":"4"}},{"id":1017735,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-10-16T20:41:41.000Z","date":"2025-10-15","kind":"sale","planned":true,"acquired":false,"shares":4500,"price":18.1554,"value":81699.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":198141,"source":{"system":"sec-edgar","filing":"0002034665-25-000006","document":"wk-form4_1760647298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000203466525000006/wk-form4_1760647298.xml","form_type":"4"}},{"id":1017734,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-10-16T20:41:41.000Z","date":"2025-10-15","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":18.1554,"value":145243.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":202641,"source":{"system":"sec-edgar","filing":"0002034665-25-000006","document":"wk-form4_1760647298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000203466525000006/wk-form4_1760647298.xml","form_type":"4"}},{"id":1017733,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-10-16T20:41:41.000Z","date":"2025-10-15","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":3.7898,"value":30318.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."}],"balance_after":210641,"source":{"system":"sec-edgar","filing":"0002034665-25-000006","document":"wk-form4_1760647298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000203466525000006/wk-form4_1760647298.xml","form_type":"4"}},{"id":1021653,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-08T21:33:28.000Z","date":"2025-10-07","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":165334,"derivative":{"exercise_price":3.7898,"expiration_date":"2033-08-08","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0002034665-25-000004","document":"wk-form4_1759959205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000203466525000004/wk-form4_1759959205.xml","form_type":"4"}},{"id":1021652,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-08T21:33:28.000Z","date":"2025-10-06","kind":"exercise","planned":true,"acquired":false,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":173334,"derivative":{"exercise_price":3.7898,"expiration_date":"2033-08-08","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0002034665-25-000004","document":"wk-form4_1759959205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000203466525000004/wk-form4_1759959205.xml","form_type":"4"}},{"id":1021651,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-10-08T21:33:28.000Z","date":"2025-10-07","kind":"sale","planned":true,"acquired":false,"shares":2900,"price":18.0591,"value":52371.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":202641,"source":{"system":"sec-edgar","filing":"0002034665-25-000004","document":"wk-form4_1759959205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000203466525000004/wk-form4_1759959205.xml","form_type":"4"}},{"id":1021650,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-10-08T21:33:28.000Z","date":"2025-10-07","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":18.0591,"value":144472.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":205541,"source":{"system":"sec-edgar","filing":"0002034665-25-000004","document":"wk-form4_1759959205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000203466525000004/wk-form4_1759959205.xml","form_type":"4"}},{"id":1021649,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-10-08T21:33:28.000Z","date":"2025-10-07","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":3.7898,"value":30318.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."}],"balance_after":213541,"source":{"system":"sec-edgar","filing":"0002034665-25-000004","document":"wk-form4_1759959205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000203466525000004/wk-form4_1759959205.xml","form_type":"4"}},{"id":1021648,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-10-08T21:33:28.000Z","date":"2025-10-06","kind":"sale","planned":true,"acquired":false,"shares":15600,"price":18.0555,"value":281665.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":205541,"source":{"system":"sec-edgar","filing":"0002034665-25-000004","document":"wk-form4_1759959205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000203466525000004/wk-form4_1759959205.xml","form_type":"4"}},{"id":1021647,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-10-08T21:33:28.000Z","date":"2025-10-06","kind":"sale","planned":true,"acquired":false,"shares":24000,"price":18.0555,"value":433332.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":221141,"source":{"system":"sec-edgar","filing":"0002034665-25-000004","document":"wk-form4_1759959205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000203466525000004/wk-form4_1759959205.xml","form_type":"4"}},{"id":1021646,"issuer":{"id":4673,"kind":"organization","name":"Bicara Therapeutics Inc.","symbol":"BCAX"},"owners":[{"id":24231,"kind":"person","name":"Cohlhepp Ryan","position":1,"cik":"0002034665","reported_name":"Cohlhepp Ryan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2025-10-08T21:33:28.000Z","date":"2025-10-06","kind":"exercise","planned":true,"acquired":true,"shares":24000,"price":3.7898,"value":90955.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."}],"balance_after":245141,"source":{"system":"sec-edgar","filing":"0002034665-25-000004","document":"wk-form4_1759959205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2034665/000203466525000004/wk-form4_1759959205.xml","form_type":"4"}}]}